Welcome : Guest

Pfizer, Inc. (USA) - Facts, Figures and Analytical Insights

Abstract

This report presents quick facts about Pfizer, Inc., which is principally a Biopharmaceutical Company. Illustrated with 216 tables, the report showcases the company's recent news stories and events, sales performance, key markets and market position as against its competitors operating in the industry.

Code: PCP-00013
Price: $3500
Company Type: Public
Pages: 225
Date: January 2017
Market Data Tables: 216

 NOTE : Select the checkbox below, and click Add to Cart button to add this report to your shopping cart.
Table 1: Pfizer, Inc.’s Sales by Product Segment Worldwide (2015) in Percentage for Innovative Products (Global Innovative Pharmaceuticals (GIP), and Global Vaccines, Oncology and Consumer Healthcare (VOC)), Global Established Pharmaceuticals (GEP) (Legacy Established Products, Peri-Loe Products, Sterile Injectable Pharmaceuticals, Infusion Systems, and Biosimilars), and Others......8
Table 2: Pfizer, Inc.’s Sales by Business Segment Worldwide (2014-2015) in Percentage for Global Innovative Pharmaceuticals (GIP), Global Vaccines, Oncology and Consumer Healthcare (VOC), Global Established Pharmaceuticals (GEP), and Others......9
Table 3: Pfizer, Inc.’s Sales by Geographic Region Worldwide (2014-2015) in Percentage for United States, Europe, and Others......10
Biopharmaceuticals......11
Table 4: Biopharmaceuticals Market by Segment Worldwide (2015) - Percentage Share Breakdown by Value for Norditropin, NovoSeven, Turoctocog Alpha, and Others......11
Vaccines......12
Table 5: Vaccines Market by Segment Worldwide (2015) - Percentage Share Breakdown by Value for Adult Prophylactic Vaccines (USD 8.5bn), Pediatric Vaccines (USD 16.7bn) and Others......12
Cancer Market......13
Table 6: Oncology/Hematology Drugs Market by Category Worldwide (2015) - Percentage Share Breakdown by Value Sales for Blood Cell Factors, Chemopreventatives, Chemotherapeutics, Mabs, Targeted Therapies, and Others......13
Table 7: Cancer Care Expenditure by Site Worldwide (2015) - Percentage Share Breakdown for Breast, Colorectal, Lymphoma, Lung, Prostate and Others*......14
Table 8: Cancer Market by Category Worldwide (2015) - Percentage Share Breakdown by Value for Heme, Lung, Prostate, and Others......15
Table 9: Oncology Market by Cancer Type Worldwide (2015) - Percentage Share Breakdown by Value for Breast Cancer, Metastatic Colorectal Cancer, Non-Small Cell Lung Cancer, and Others......16
Table 10: Clinical Oncology Market by Region Worldwide (2015) - Percentage Share Breakdown by Value Sales for US, and Others......17
Table 11: Hereditary Oncology Market by Region Worldwide (2015) - Percentage Share Breakdown by Value Sales for US, and Others......18
Table 12: Cancer Market by Type in China (2015) - Percentage Share Breakdown by Value for Breast, Colorectal, Esophagus, Liver, Lung, Stomach and Others......19
Table 13: Oncology Market by Category in China (2015) - Percentage Share Breakdown by Value for Anti- Tumor Agents, Hormone Therapy, Immuno Suppresants and Immunostimulants......20
Table 14: Number of Cancer Patients by Type Worldwide (2015) - Percentage Share Breakdown by Volume for Bladder, Breast, Cervix Uteri, Colorectum, Liver, Lung, Non-Hodgkin lymphoma, Oesophagus, Prostate, and Stomach......21
Table 15: New Patients with Cancer by Site in the US (2015) - Percentage Market Share Breakdown by volume for Colorectal, Lung and Bronchus, Melanoma, Pancreas, and Others......22
Table 16: Number of Cancer Patients by Type in the US (2015) - Percentage Share Breakdown by Volume for Bladder Cancer, Breast Cancer (Female), Colon and Rectum Cancer, Endometrial Cancer, Kidney and Renal Pelvis Cancer, Lung and Bronchus Cancer, Melanoma of the Skin, Non-Hodgkin Lymphoma, Prostate Cancer, and Thyroid Cancer......23
Table 17: No. of Cancer Patients Death by Type in the US (2015) - Percentage Share Breakdown for Breast, Colorectal, Lung, Melanoma, and Prostate......24
Table 18: Oncology Market by Segment in the US (2015) - Percentage Share Breakdown by Value for Solid Tumor and Others......25
Table 19: No. of Cancer Patients by Type in the US (2015) - Percentage Market Share Breakdown for Colorectal Cancer (CRC), Melanoma, Non-Squamous Non-Small-Cell Lung Cancer (NSCLC), Ovarian, Prostate, Renal Cell Carcinoma (RCC), and Squamous Non-Small-Cell Lung Cancer (NSCLC)......26
Anti-Cancer Drugs......27
Table 20: Anti-Cancer Drugs Market by Product Type in China (2015) - Percentage Share Breakdown by Value for Anastrozole, Capecitabine, Cetuximab, Compound kushen, Docetaxel, Epirubicin, Erlotinib, Gefitinib, Gemcitabine, Goserelin, Interferon α-2a, Interferon α-2b, Irinotecan, Kangai, Lentinan, Letrozole, Oxaliplatin, Paclitaxel, Pemetrexed, Pidotimod, RhG-CSF, RhIL-2, Rituximab, Sorafenib, Sshenqi Fuzheng, Thymopentin, Thymosin a1, Trastuzmmab, Triptorelin, TS-1, and Others......27
Table 21: Anti-Cancer Drugs Market by Type in China (2015) - Percentage Share Breakdown by Value for Alkylating Agents, Antibiotics, Antimetabolites, Hormonal Agents, Immunostimulant, Plant Alkaloids, and Others......28
Bladder Cancer......29
Table 22: No. of Bladder Cancer Patients by Category in the US (2015) - Percentage Market Share Breakdown for Invasive Patients, and Non-Invasive Patients......29
Breast Cancer......30
Table 23: Breast Cancer Diagnoses by Hospital Type in the US (2015) - Percentage Share Breakdown by Volume for Community, Comprehensive, Teaching and Research, and Others......30
Cervical Cancer......31
Table 24: Cervical Cancer Market by HPV Type in England (2015) - Percentage Share Breakdown by Value for HPV 16, HPV 18, HPV 33, HPV 45, and Others......31
Table 25: Cervical Cancer Market by HPV Type in Europe (2015) - Percentage Share Breakdown by Value for HPV 16, HPV 18, HPV 31, HPV 33, and Others......32
Colorectal Cancer......33
Table 26: No. of Colorectal Cancer Patients by Region Worldwide (2015) - Percentage Market Share Breakdown for Asia, Australia, Europe, and US......33
Hematological Cancer......34
Table 27: Hematological Cancer by Category Worldwide (2015) - Percentage Market Share Breakdown by Value Sales for Chronic Lymphocytic Leukemia (CLL), Multiple Myeloma (MM), and Non-Hodgkin’s Lymphoma (NHL)......34
Invasive Breast Cancer......35
Table 28: No. of Invasive Breast Cancer Patients by Category Worldwide (2015) - Percentage Market Share Breakdown for Stage I and Stage II-III......35
Table 29: No. of Invasive Breast Cancer Patients by Category in the US (2015) - Percentage Market Share Breakdown for Stage I and Stage II-III......36
Primary Liver Cancer......37
Table 30: No. of Primary Liver Cancer Patients by Region Worldwide (2015) - Percentage Market Share Breakdown for Asia, Australia, Europe, and US......37
Skin Cancer......38
Table 31: Skin Cancer by Type Worldwide (2015) - Percentage Market Share Breakdown by Volume for Basal Cell Carcinomas, Melanoma, and Squamous Cell Carcinomas......38
Cancer in Stage 3/4......39
Table 32: New Patients with Cancer in Stage 3/4 by Site in the US (2015) - Percentage Market Share Breakdown by Volume for Colorectal, Lung and Bronchus, Pancreas and Others......39
Solid Cancer Tumor Patients......40
Table 33: No. of Solid Cancer Tumor Patients by Type Worldwide (2015) - Percentage Share Breakdown for Breast Cancer, Colorectal Cancer, Lung Cancer, Melanoma, and Prostate Cancer......40
Cancer-Associated Mucositis......41
Table 34: Cancer-Associated Mucositis Market by Activity Worldwide (2015) - Percentage Share Breakdown by Value for Breast, Colorectal, Head and Neck, Non-Small Cell Lung cancer and Others......41
Cancer Drugs......42
Table 35: Oncology Drug Market by Region Worldwide (2015) - Percentage Share Breakdown by Value for European Union Five, Japan, US and Others......42
Chronic Lymphocytic Leukemia (CLL)......43
Table 36: No. of Chronic Lymphocytic Leukemia (CLL) (1L) Patients by Category Worldwide (2015) - Percentage Market Share Breakdown for Imbruvica PCYC, Rituxan, Gazyva ROG, and Others......43
Table 37: No. of Chronic Lymphocytic Leukemia (CLL) (1L) Patients by Category in European Union (2015) - Percentage Market Share Breakdown for Rituxan, Gazyva, and Others......44
Table 38: No. of Chronic Lymphocytic Leukemia (CLL) (R/R) Patients by Category in European Union (2015) - Percentage Market Share Breakdown for Rituxan, Gazyva, and Others......45
Chronic Myelogenous Leukemia (CML)......46
Table 39: Chronic Myelogenous Leukemia (CML) Market by Region Worldwide (2015) - Percentage Share Breakdown by Value Sales for Asia-Pacific, Canada, European Union, Japan, USA, and Others......46
Cutaneous Melanoma......47
Table 40: No. of Cutaneous Melanoma Patients by Region Worldwide (2015) - Percentage Market Share Breakdown for Asia, Australia, Europe, and US......47
Ocular Melanoma......48
Table 41: No. of Ocular Melanoma Patients by Region Worldwide (2015) - Percentage Market Share Breakdown for Asia, Australia, Europe, and US......48
Female Mortality......49
Table 42: Female Mortality by Cancer Type in China (2015) - Percentage Market Share Breakdown by Volume for Lung, Breast, Colon, Rectum and Anus, Intestine, Liver, and Others......49
Male Mortality......50
Table 43: Male Mortality by Cancer Type in China (2015) - Percentage Market Share Breakdown by Volume for Colon, Colon, Rectum and Anus, Intestine, Liver, Lung, and Others......50
Nausea and Vomiting Associated With Cancer Chemotherapy......51
Table 44: Nausea and Vomiting Associated With Cancer Chemotherapy Market by Drug in European Union (2015) - Percentage Share Breakdown by Value for Aprepitant (Emend), Netupitant (Akynzeo), and Rolapitant (Varubi)......51
Multiple Myeloma......52
Table 45: Multiple Myeloma by Age Group Worldwide (2015) - Percentage Share Breakdown by No. of New Cases for 45-54, 55-64, 65-74, 75-84, >84, and Others......52
Table 46: Multiple Myeloma Market by Category Worldwide (2015) - Percentage Share Breakdown by Value Sales for Kyprolis AMGN, Pomalyst CELG, Revlimid CELG, Thalomid CELG, and Velcade TKD/JNJ......53
Non Small Cell Lung Cancer Patients......54
Table 47: No. of Non Small Cell Lung Cancer Patients by Category in the US (2015) - Percentage Market Share Breakdown for Stage I, Stage II-III, Stage III-IV, and Undiagnozed......54
Dietary Supplements......55
Table 48: Dietary Supplements Retail Market by Category Worldwide (2015) - Percentage Share Breakdown by Value Sales for Fish Oil, Glucosamine, Krill Oil, Magnesium, Multi-Vitamins, Vitamin B, Vitamin C, Vitamin D, Other Herbal, and Others......55
Table 49: Dietary Supplements Market by Distribution Channels in the US (2015) - Percentage Share Breakdown by Value for Health Food and Specialized Stores, Healthcare Practitioners, Internet, Mail Order, TV, and Radio, Mass Market, and Multi-level Marketing......56
Table 50: Dietary Supplements Market by Nutrients in the US (2015) - Percentage Share Breakdown by Value for Herbal and Botanical Supplements, Meal Supplements, Mineral Supplements, Specialty Supplements, Sports Supplements, and Vitamin Supplements......57
Vitamins and Dietary Supplements......58
Table 51: Vitamins and Supplements Market by Country Worldwide (2015) - Percentage Share Breakdown by Value Sales for China, European Union, Japan, USA and Others......58
Table 52: Vitamins and Supplements Retail Market by Category Worldwide (2015) - Percentage Share Breakdown by Value for Dietary Supplements, Paediatric Vitamins and Supplements, Tonics and Nutritive, and Vitamins......59
Table 53: Vitamins Market by Type Worldwide (2015) - Percentage Share Breakdown by Value for A, B, C, E, and Others......60
Table 54: Vitamins Sales by Category Worldwide (2015) - Percentage Share Breakdown by Value for Animal, and Human......61
Table 55: Vitamins and Dietary Supplements (VDS) Market by Category in the US (2015) - Percentage Share Breakdown by Value for Private-Label and Others......62
Table 56: Vitamin and Supplements Market by Channel in the US (2015) - Percentage Breakdown by Value for Mass Marketers, Specialty Retailers, and Others......63
Table 57: Vitamins Sales by Category through Supermarkets, Drug Stores and Mass Merchandisers (including Wal-Mart), Military Commissaries and Select Club and Dollar Stores in the US (2015) - Percentage Share Breakdown by Value for Adult Multivitamins, Calcium, Children's Multivitamins, Vitamin B, Vitamin C, Vitamins A&D, and Others......64
Table 58: Vitamins Sales through Supermarkets, Drug Stores, Mass Merchandisers (including Wal-Mart), Military Commissaries and Select Dollar and Club Chains by Sector in the US (2015) - Percentage Share Breakdown by Value for 1 & 2 Letter, Liquid Vitamins & Minerals, Mineral Supplements, and Multivitamins......65
Gastrointestinal Drugs......66
Table 59: Gastrointestinal Market Worldwide (2015) in US$ Million......66
Table 60: Gastrointestinal Drugs Market by Category Worldwide (2015) - Percentage Share Breakdown by Value Sales for H2 Blockers, Proton Pump Inhibitors, and Others......67
Respiratory Drugs......68
Table 61: Respiratory Market by Category Worldwide (2015) - Percentage Share Breakdown by Value for Prevention, Rescue, and Rhinitis......68
Table 62: Respiratory Therapeutic Market by Category Worldwide (2015) - Percentage Share Breakdown by Value for Prevention, Rescue and Rhinitis......69
Atypical Drugs......70
Table 63: New Prescription Market for Atypical Antipsychotic Drugs in the US (2015) - Percentage Share Breakdown by Value Sales for Abilify (Otsuka/ Bristol-Myers Squibb Company), Fanapt (Novartis), Geodon (Pfizer, Inc.), Invega (Johnson & Johnson), Latuda (Sunovion), Olanzapine (Generic Zyprexa), Risperidone (Generic Risperdal), Saphris (Merck & Company, Inc.), Seroquel (AstraZeneca Plc), and Zyprexa (Eli Lilly and Company)......70
Migraine Drugs......71
Table 64: Migraine Drugs Market by Category in the US (2015) - Percentage Share Breakdown by Prescriptions for Amerge Generic (Naratriptan), Imitrex Generic (Sumatriptan), Maxalt Generic (Rizatriptan), Relpax (Pfizer), and Zomig Generic (Zolmitriptan)......71
Human Growth Hormone......72
Table 65: Human Growth Hormone Sales by Product in the US (2015) - Percentage Share Breakdown by Value for Genotropin (Pfizer), Humatrope (Eli Lilly), Norditropin (Novo Nordisk), Nutropin (Roche), Saizen, serostim (Merck KGaA) and Others......72
Pharmaceutical Benefits Scheme (PBS) Prescription......73
Table 66: Pharmaceutical Benefits Scheme (PBS) Prescription Market by Company in Australia (2014) - Percentage Market Share Breakdown by Volume Sales for Alphapharm, AstraZeneca Plc, Eli Lilly and Company, GlaxoSmithKline Plc, Janssen Pharmaceuticals, Merck & Co., Inc., Novartis, Pfizer, Inc., Sanofi S.A., Wyeth, and Others......73
Infusion Systems......74
Table 67: Infusion Systems Market by Segment in the US (2015) - Percentage Share Breakdown by Value for Enteral Feeding Pumps, Implantable Drug Infusion Pumps, Insulin Infusion Pumps, Large Volume Infusion Pumps, and Others......74
Infusion Sets......75
Table 68: Non-Polyvinyl Chloride (PVC) Infusion Set Market by Country Worldwide (2015) - Percentage Share Breakdown by Value for US, and Others......75
Table 69: Infusion Sets Market by Region in China (2015) - Percentage Share Breakdown by Value Sales for Beijing, Guangdong, Jiangsu, and Others......76
Biosimilars......77
Table 70: Biosimilars Market by Segment Worldwide (2015) - Percentage Share Breakdown by Value for Erythropoietin (EPO), Filgrastim, New Biosimilars, and Somatropin......77
Pharmaceuticals......78
Table 71: Market Shares of Leading Pharmaceutical Companies in Indonesia (2015) - Percentage Breakdown by Value Sales for Dexa Medica Group, PT Kalbe Farma Tbk., Pfizer Indonesia PT Tbk, Sanbe Farma PT, and Others......78
Biopharmaceuticals......79
Table 72: Market Shares of Leading Biopharmaceutical Companies Worldwide (2014) - Percentage Breakdown by Volume (Installed Capacity) for Amgen Inc., Biogen Idec, Inc., Bristol-Myers Squibb Company, C.H. Boehringer Sohn AG & Co. KG, Eli Lilly and Company, F. Hoffmann-La Roche Ltd., Johnson & Johnson Ltd., Lonza Group Ltd., Pfizer, Inc., Sanofi S.A., and Others......79
Table 73: Market Shares of Leading Biopharmaceutical Companies in the US (2015) - Percentage Market Share Breakdown by Value for Actelion Pharmaceuticals Ltd., Alexion Pharmaceuticals, Inc., Celgene Corporation, Gilead Sciences, Inc., Incyte, Corporation, Isis Pharmaceuticals, Inc., Vertex Pharmaceuticals, Inc., and Others......80
Generic Pharmaceutical......81
Table 74: Market Shares of Leading Generic Pharmaceutical Companies by Value Sales in India (2014) - Percentage Breakdown for Abbott India Ltd., Alkem Laboratories Ltd., Cipla Ltd., GlaxoSmithKline Pharmaceuticals Ltd. (GSK), Lupin Ltd., Mankind Pharma, Pfizer Ltd., Ranbaxy Laboratories Ltd., Sun Pharmaceutical Industries Ltd., Zydus Cadila and Others......81
Vaccines......82
Table 75: Market Shares of Leading Vaccine Manufacturers by Value Sales Worldwide (2014) - Percentage Breakdown for GlaxoSmithKline Plc (GSK), Merck & Co., Inc., Novartis International AG, Pfizer, Inc., Sanofi S.A., and Others......82
Diphtheria and Tetanus Vaccines......83
Table 76: Market Shares of Leading Diphtheria and Tetanus Vaccine Manufacturers by Value Sales in India (2014) - Percentage Breakdown for GlaxoSmithKline Plc (Infanrix), and Others......83
Hepatitis A Vaccines......84
Table 77: Market Shares of Leading Hepatitis A Vaccine Manufacturers by Value Sales in India (2014) - Percentage Breakdown for GlaxoSmithKline Plc (Havrix), and Others......84
Hepatitis B (Recombinant) Vaccines......85
Table 78: Market Shares of Leading Hepatitis B (Recombinant) Vaccine Manufacturers by Value Sales in India (2014) - Percentage Breakdown for Engerix (GlaxoSmithKline Plc), and Others......85
Hepatitis A and Typhoid Polysaccharide Vaccines......86
Table 79: Market Shares of Leading Hepatitis A and Typhoid Polysaccharide Vaccine Manufacturers by Value Sales in India (2014) - Percentage Breakdown for GlaxoSmithKline Plc (Hepatyrix), and Others......86
Hemophilia Medicine......87
Table 80: Market Shares of Leading Hemophilia Medicine Manufacturers by Value Sales Worldwide (2014) - Percentage Breakdown for Baxter International, Inc., Bayer AG, CSL Limited, Grifols, S.A., Kedrion S.p.A, Novo Nordisk A/S, Octapharma AG, and Pfizer, Inc.......87
Haemophilia A Treatment Products......88
Table 81: Market Shares of Leading Hemophilia Treatment Manufacturers Worldwide (2015) - Percentage Breakdown by Value for Baxter International, Inc., Bayer AG, CSL Ltd. Novo Nordisk, Pfizer, Inc., and Others......88
Table 82: Market Shares of Leading Haemophilia A Treatment Product Manufacturers Worldwide (2015) - Percentage Breakdown by Value Sales for Baxter International Inc. (Advate), Bayer AG (Kogenate), CSL Behring, LLC (Helixate), Pfizer, Inc. (Refacto) and Others......89
Haemophilia B......90
Table 83: Market Shares of Leading Haemophilia B Treatment Product Manufacturers Worldwide (2015) - Percentage Breakdown by Value Sales for Pfizer, Inc. (Benefix) and Others......90
Human Papillomavirus Vaccines......91
Table 84: Market Shares of Leading Human Papillomavirus Vaccine Manufacturers by Value Sales in India (2014) - Percentage Breakdown for GlaxoSmithKline Plc (Cervarix), and Others......91
Human Rotavirus Vaccines......92
Table 85: Market Shares of Leading Human Rotavirus Vaccine Manufacturers by Value Sales in India (2014) - Percentage Breakdown for GlaxoSmithKline Plc (Rotarix), and Others......92
Influenza Vaccines......93
Table 86: Market Shares of Leading Influenza Vaccine Manufacturers by Value Sales in India (2014) - Percentage Breakdown for GlaxoSmithKline Plc (Fluarix), and Others......93
Measles, Mumps and Rubella Vaccines......94
Table 87: Market Shares of Leading Measles, Mumps and Rubella Vaccine Manufacturers by Value Sales in India (2014) - Percentage Breakdown for GlaxoSmithKline Plc (Priorix), and Others......94
Tetanus Toxoid, reduced Diphthera Vaccines......95
Table 88: Market Shares of Leading Tetanus Toxoid, reduced Diphthera Vaccine Manufacturers in India (2014) - Percentage Breakdown by Value Sales for GlaxoSmithKline Plc (Boostrix), and Others......95
Typhoid Vaccines......96
Table 89: Market Shares of Leading Typhoid Vaccine Manufacturers by Value Sales in India (2014) - Percentage Breakdown for GlaxoSmithKline Plc (Typherix), and Others......96
Varilrix Vaccines......97
Table 90: Market Shares of Leading Varilrix Vaccine Manufacturers by Value Sales in India (2014) - Percentage Breakdown for GlaxoSmithKline Plc (Varilrix), and Others......97
Cancer Drugs......98
Table 91: Market Shares of Leading Oncology Product Manufacturers Worldwide (2015) - Percentage Breakdown by Value for Fresenius SE & Co., and Others......98
Table 92: Market Shares of Leading Oncology/Hematology Therapeutic Providers by Value Sales Worldwide (2014) - Percentage Breakdown for AbbVie, Amgen, Inc., AstraZeneca Plc, Bristol-Myers Squibb Company, Eli Lilly and Company, F. Hoffmann-La Roche AG, GlaxoSmithKline Plc, Johnson & Johnson, Merck Ltd., Novartis AG, Pfizer, Inc., Sanofi S.A., and Others......99
Table 93: Market Shares of Leading Oncology Drug Manufacturers in China (2015) - Percentage Share Breakdown by Value for Astrazeneca, Jiangsu Hengrui Medicine Co., Ltd., Roche Group and Others......100
Breast Cancer Drugs......101
Table 94: Market Shares of Leading Breast Cancer Drugs by Value Sales in China (2014) - Percentage Breakdown for Alkylating Agents, Antimetabolite, Antitumor Antibiotics, Antitumor Antihormone, Antitumor Botanicals, Monoclonal Antibodies, Targeted Small Molecule Agents, and Others......101
Relapsed/Refractory (RR) Chronic Lymphocytic Leukemia (CLL)......102
Table 95: Market Shares of Leading Drugs for Treatment of Relapsed/Refractory (RR) Chronic Lymphocytic Leukemia (CLL) in the US (2015) - Percentage Share Breakdown by Value for Ibrutinib, Idelalisib and Others......102
Relapsed/Refractory (RR) Indolent Non-Hodgkin's Lymphoma (iNHL)......103
Table 96: Market Shares of Leading Drugs for Treatment of Relapsed/Refractory (RR) Indolent Non-Hodgkin's Lymphoma (iNHL) in the US (2015) - Percentage Share Breakdown by Value for Ibrutinib, Idelalisib and Other......103
Table 97: Market Shares of Leading Drugs for Treatment of Relapsed/Refractory Aggressive Non-Hodgkin Lymphoma (R/R- aNHL) in the US (2015) - Percentage Share Breakdown by Value for Ibrutinib and Others......104
Dietary Supplements......105
Table 98: Market Shares of Leading Dietary Supplements Brands in India (2015) - Percentage Share Breakdown by Value for Zandu Sona Chandi ChywanPrash Plus & Zandu Kesari Jivan, and Others......105
Table 99: Market Shares of Leading Dietary Supplements Manufacturers in India (2015) - Percentage Share Breakdown by Value for Amway India, Emami Ltd., Heinz India Pvt Ltd., and Others......106
Gastrointestinal Drugs......107
Table 100: Market Shares of Leading Gastrointestinal, Ulcer Medicine Manufacturers by Value Sales Worldwide (2014) - Percentage Breakdown for AbbVie, AstraZeneca Plc, Forest Laboratories, Inc., GlaxoSmithKline Plc, Johnson & Johnson, Pfizer, Inc., and Others......107
Table 101: Market Shares of Leading Gastrointestinal Medicine Manufacturers by Value Sales in India (2015) - Percentage Breakdown for Torrent Pharmaceuticals Ltd., and Others......108
Table 102: Market Shares of Leading Gastrointestinal (GI) Remedies Manufacturers for Over- the-Counter (OTC) Sector in the US (2015) - Percentage Breakdown by Value for GlaxoSmithKline Pharmaceuticals Limited, Johnson & Johnson Private Limited, Novartis Consumer Health, Inc., Prestige Brands Holdings, Inc., Procter & Gamble Co., Private Label and Others......109
Table 103: Market Shares of Leading Gastrointestinal Medicine Manufacturers by Value Sales in the US (2015) - Percentage Share Breakdown for Procter & Gamble Co., and Others......110
Table 104: Market Shares of Leading Gastrointestinal Medicine Manufacturers by Volume Sales in the US (2015) - Percentage Share Breakdown for Procter & Gamble Co., and Others......111
Pain Management Drugs......112
Table 105: Market Shares of Leading Pain Management Therapeutic Providers by Value Sales Worldwide (2014) - Percentage Breakdown for AstraZeneca Plc, Endo International Plc, Johnson & Johnson, Pfizer, Inc., and Others......112
Table 106: Market Shares of Leading Pain Remedies Manufacturers for Over-the-Counter (OTC) Sector in the US (2015) - Percentage Breakdown by Value for Bayer HealthCare AG, Johnson & Johnson Private Limited, Pfizer, Inc., Prestige Brands Holdings, Inc., Private-label and Others......113
Table 107: Market Shares of Leading Pain Remedy Producers Sales in the US OTC Market (2014) - Percentage Breakdown by Value for Bayer AG, Johnson & Johnson, Novartis AG, Pfizer, Inc., Prestige Brands Holdings, Inc., Private Label and Others......114
Table 108: Market Shares of Leading Oral Pain Relief Brands through Food Store in the US (2015) - Percentage Share Breakdown by Value for Anbesol, Baby Orajel, Kank A, Kank A Softbrush, Orajel, Private Label, and Others......115
Table 109: Market Shares of Leading Oral Pain Relief Brands through Supermarkets, Drugstores, Mass Merchandisers (including Wal-Mart), Gas & Convenience Stores, Military Commissaries, and Select Club and Dollar Retail Chains in the US (2015) - Percentage Share Breakdown by Value for Anbesol, BabyOrajel, Hyland's, KankA, Orajel, and Other......116
Table 110: Market Shares of Leading Oral Pain Remedy Brands by Value Sales through Supermarkets, Drug Stores and Mass Merchandisers (excluding Wal-Mart) in the US (2015) - Percentage Share Breakdown for Anbesol, Baby Orajel, Glyoxide, Kank-A, Orajel, Private Label, and Others......117
Injectable Drugs......118
Table 111: Market Shares of Leading Injectable Drug Manufacturers Worldwide (2015) - Percentage Breakdown by Value for Fresenius SE & Co. KGaA, Hospira, Inc., Novartis AG, Pfizer, Inc., West-Ward Pharmaceuticals Corporation, and Others......118
Table 112: Market Shares of Leading Generic Injectable Manufacturers by Value Sales Worldwide (2014) - Percentage Breakdown for Fresenius SE & Co., Hikma Pharmaceuticals, Hospira, Inc., Luitpold Pharmaceuticals, Inc. and Others......119
Table 113: Market Shares of Leading Injectable Manufacturers by Value Sales in France (2014) - Percentage Breakdown for Aguettant Limited, Baxter International, Inc., B. Braun Melsungen AG, F. Hoffmann-La Roche Ltd., Lake Forest Park Medical Clinic (LFP), Mylan Laboratories, Inc., Novartis International AG (Sandoz), Laboratoires PANPHARMA S.A., Sanofi S.A., and Others......120
Table 114: Market Shares of Leading Injectable Manufacturers by Value Sales in Germany (2014) - Percentage Breakdown for AstraZeneca Plc, Baxter International, Inc., Fresenius SE & Co., Medac GmbH, Novartis International AG (Sandoz), Sanofi S.A.,Teva Pharmaceutical Industries Ltd. and Others......121
Table 115: Market Shares of Leading Injectable Manufacturers by Value Sales in Italy (2014) - Percentage Breakdown for F. Hoffmann-La Roche Ltd., Hospira, Inc., Johnson & Johnson, KEDRION GROUP S.p.A., Novartis International AG (Sandoz), Pfizer, Inc., Sanofi S.A., Teva Pharmaceutical Industries Ltd. and Others......122
Table 116: Market Shares of Leading Injectable Manufacturers by Value Sales in Spain (2014) - Percentage Breakdown for F. Hoffmann-La Roche Ltd., Ges Genericos Españoles Laboratorio S.A., Grifols, S.A, Hospira, Inc., Johnson & Johnson, Normon S.A., Sanofi S.A., Teva Pharmaceutical Industries Ltd., and Others......123
Table 117: Market Shares of Leading Injectable Manufacturers by Value Sales in the UK (2014) - Percentage Breakdown for Actavis Plc (Watson), AstraZeneca Plc, Baxter International, Inc., Fresenius SE & Co., Hospira, Inc., Sanofi S.A., Teva Pharmaceutical Industries Ltd., and Others......124
Table 118: Market Shares of Leading Injectable Miotics Manufacturers in the US (2015) - Percentage Breakdown by Value for Alcon Incorporated, and Novartis International AG......125
Infusion Pumps......126
Table 119: Market Shares of Leading Infusion Pump Manufacturers by Value Sales Worldwide (2014) - Percentage Breakdown for B. Braun Melsungen AG, Baxter International, Inc., CareFusion Corporation, Hospira, Inc. and Others......126
Advanced Infusion Sets......127
Table 120: Market Shares of Leading Advanced Infusion Sets Suppliers in China (2015) - Percentage Breakdown by Volume for Hongda Xingye Co., Ltd., Jiangsu Suyun Medical Materials Co., Ltd., PW Medtech Group Limited, Qiaopai Group Co., Ltd., Shinva Medical Instrument Co., Ltd., TianJin Hanaco Xingda Medical CO., Ltd., Weigao Group, Co., Ltd., and Others......127
Table 121: Market Shares of Leading Advanced Infusion Sets Suppliers in China (2015) - Percentage Share Breakdown by Value for Jiangsu PW Medtech Group Limited, Shinva Medical Instrument Co., Ltd., TianJin Hanaco Xingda Medical CO., Ltd., Weigao Group, Co., Ltd., and Others......128
Precision Filter Infusion Sets......129
Table 122: Market Shares of Leading Precision Filter Infusion Sets Suppliers in China (2015) - Percentage Breakdown by Volume for Hongda Xingye Co., Ltd., Jiangsu Suyun Medical Materials Co., Ltd., PW Medtech Group Limited, Qiaopai Group Co., Ltd., Shinva Medical Instrument Co., Ltd., TianJin Hanaco Xingda Medical CO., Ltd., Weigao Group, Co., Ltd., and Others......129
Infusion Devices......130
Table 123: Market Shares of Leading Infusion Device Manufacturers by Value Sales Worldwide (2014) - Percentage Breakdown for B. Braun Melsungen AG, Baxter International, Inc., CareFusion Corporation, Fresenius SE & Co., Hospira, Inc., Terumo Corporation, and Others......130
Infusion Therapy Equipment......131
Table 124: Market Shares of Leading Infusion Therapy Equipment Manufacturers by Value Sales in the US (2015) - Percentage Breakdown for B. Braun Melsungen AG, Baxter International, Inc., CareFusion Corporation, Hospira, Inc., and Others......131
Biosimilars......132
Table 125: Market Shares of Leading Biosimilar Drug Producing Companies in Europe (2015) - Percentage Share Breakdown by Value for Hospira, Inc., Sandoz, Teva Pharmaceuticals Industries Ltd. and Others......132
Growth Hormone......133
Table 126: Market Shares of Leading Growth Hormone Manufacturers Worldwide (2015) - Percentage Share Breakdown by Value for Eli Lilly and Company (humatrope), Novo Nordisk (Norditropin), Pfizer, Inc. (Genotropin), Roche Holdings AG (Nutropin) and Others......133
Human Growth Hormones (HGH)......134
Table 127: Market Shares of Leading Human Growth Hormones (HGH) Producers Worldwide (2015) - Percentage Breakdown by Value for Eli Lilly and Company (Humatrope), Merck KGaA (Saizen,Serostim), Novo Nordisk A/S (Norditropin), Pfizer Inc. (Genotropin), Roche Holding AG (Nutropin), Teva Pharmaceutical Industries Ltd. (Tev-Tropin) and Others......134
Table 128: Market Shares of Leading Human Growth Hormones (HGH) Producers in the US (2015) - Percentage Breakdown by Value for Eli Lilly and Company, Genentech, Inc. and Roche Holding AG, Merck KGaA, Novartis International AG, Novo Nordisk A/S, Pfizer, Inc. and Teva Pharmaceutical Industries Ltd.......135
Infant Formula......136
Table 129: Market Shares of Leading Infant Formula Manufacturers Worldwide in 2014: Percentage Shares in Sales Value held by Abbott Nutrition, Groupe Danone, Mead Johnson & Company, Nestle SA, and Pfizer, Inc.......136
Table 130: Market Shares of Leading Infant Formula Manufacturers in Australia in 2014: Percentage Shares in Sales Value held by Groupe Danone, H. J. Heinz Company, Nestle SA, and Pfizer, Inc.......137
Table 131: Market Shares of Leading Infant Formula Manufacturers in Chile in 2014: Percentage Shares in Sales Value held by Abbott Nutrition, Mead Johnson & Company, Nestle SA, and Pfizer, Inc.......138
Table 132: Market Shares of Leading Infant Formula Manufacturers in China in 2014: Percentage Shares in Sales Value held by Groupe Danone, Hangzhou Beingmate Group, Mead Johnson & Company, Nestle SA, and Pfizer, Inc.......139
Table 133: Market Shares of Leading Infant Formula Manufacturers in Colombia in 2014: Percentage Shares in Sales Value held by Abbott Nutrition, Groupe Danone, Mead Johnson & Company, Nestle SA, and Pfizer, Inc.......140
Table 134: Market Shares of Leading Infant Formula Manufacturers in Egypt in 2014: Percentage Shares in Sales Value held by Groupe Danone, Nestle SA, and Pfizer, Inc......141
Table 135: Market Shares of Leading Infant Formula Manufacturers in Indonesia in 2014: Percentage Shares in Sales Value held by Abbott Nutrition, Groupe Danone, Mead Johnson & Company, Nestle SA, and Pfizer, Inc.......142
Table 136: Market Shares of Leading Infant Formula Manufacturers in Malaysia in 2014: Percentage Shares in Sales Value held by Abbott Nutrition, Groupe Danone, Mead Johnson & Company, Nestle SA, and Pfizer, Inc.......143
Table 137: Market Shares of Leading Infant Formula Manufacturers in Mexico in 2014: Percentage Shares in Sales Value held by Abbott Nutrition, Mead Johnson & Company, Nestle SA, and Pfizer, Inc.......144
Table 138: Market Shares of Leading Infant Formula Manufacturers in Philippines (2015) - Percentage Breakdown by Value for Abbott Laboratories, Mead Johnson Nutrition Company, Nestlé S.A, Pfizer Inc. and Others......145
Table 139: Market Shares of Leading Infant Formula Manufacturers in Saudi Arabia (2015) - Percentage Breakdown by Value for Abbott Laboratories, Danone Group S.A, Nestlé S.A, Pfizer and Others......146
Table 140: Market Shares of Leading Infant Formula Manufacturers in South Africa in 2014: Percentage Shares in Sales Value held by Abbott Nutrition, Nestle SA, and Pfizer, Inc.......147
Table 141: Market Shares of Leading Infant Formula Manufacturers in Taiwan in 2014: Percentage Shares in Sales Value held by Abbott Nutrition, Mead Johnson & Company, Nestle SA, and Pfizer, Inc.......148
Table 142: Market Shares of Leading Infant Formula Manufacturers in Thailand in 2014: Percentage Shares in Sales Value held by Abbott Nutrition, Groupe Danone, Mead Johnson & Company, Nestle SA, and Pfizer, Inc.......149
Table 143: Market Shares of Leading Infant Formula Manufacturers in UK in 2014: Percentage Shares in Sales Value held by Groupe Danone, HiPP UK Ltd., Mead Johnson & Company, and Pfizer, Inc.......150
Infant Milk Powder......151
Table 144: Market Shares of Leading Infant Milk Powder Manufacturers by Value Sales in China (2015) - Percentage Share Breakdown for Abbott Laboratories, Beingmate Baby & Child Food Co., Ltd., Groupe Danone, Mead Johnson & Co., LLC, Pfizer, Inc., Yili Com., Inc., and Others......151
Therapeutic Providers......152
Table 145: Market Shares of Leading Therapeutic Providers (Alzheimer's Disease, Bone Diseases, Cardiology, CNS, Dermatology, Diabetes/Metabolic, Epilepsy, G.I./Ulcer, HBV/HCV, Infectious Disease, Multiple Sclerosis, Obesity, Onc./Hematology, Ophthalmology, Orphan Disease, Pain Management, Respiratory, Rheumatology, Sleep Disorders, Urinary Incont., and Women's Health) by Value Sales Worldwide (2014) - Percentage Breakdown for AbbVie, Amgen, Inc., AstraZeneca Plc, Biogen Idec, Inc., Bristol-Myers Squibb Company, Eli Lilly and Company, Endo International Plc, F. Hoffmann-La Roche AG, Forest Laboratories, Inc., GlaxoSmithKline Plc, Johnson & Johnson, Merck Ltd., Novartis AG, Novo Nordisk A/S, Pfizer, Inc., Sanofi S.A., and Others......152
Respiratory Therapeutics......153
Table 146: Market Shares of Leading Respiratory Therapeutic Providers by Value Sales Worldwide (2014) - Percentage Breakdown for AstraZeneca Plc, F. Hoffmann-La Roche AG, Forest Laboratories, Inc., GlaxoSmithKline Plc, Merck Ltd., Novartis AG, Pfizer, Inc., Sanofi S.A., and Others......153
Bone Diseases Therapeutics......154
Table 147: Market Shares of Leading Bone Diseases Therapeutic Providers by Value Sales Worldwide (2014) - Percentage Breakdown for Amgen, Inc., Eli Lilly and Company, GlaxoSmithKline Plc, Merck Ltd., Novartis AG, Pfizer, Inc., F. Hoffmann-La Roche AG, Sanofi S.A., and Others......154
Rheumatology Therapeutics......155
Table 148: Market Shares of Leading Rheumatology Therapeutic Providers by Value Sales Worldwide (2014) - Percentage Breakdown for AbbVie, Amgen, Inc., Bristol-Myers Squibb Company, F. Hoffmann-La Roche AG, GlaxoSmithKline Plc, Johnson & Johnson, Merck Ltd., Novartis AG, Pfizer, Inc., Sanofi S.A., and Others......155
Urinary Incontinence Therapeutics......156
Table 149: Market Shares of Leading Urinary Incontinence Therapeutic Providers by Value Sales Worldwide (2014) - Percentage Breakdown for Eli Lilly and Company, Johnson & Johnson, Novartis AG, Pfizer, Inc., and Others......156
Alzheimer Disease Therapeutics......157
Table 150: Market Shares of Leading Alzheimer Disease Therapeutic Providers by Value Sales Worldwide (2014) - Percentage Breakdown for Forest Laboratories, Inc., Johnson & Johnson, Novartis International AG, Pfizer, Inc., and Others......157
Table 151: Market Shares of Leading Donepezil Tablet Brands in Brazil (2015) - Percentage Share Breakdown by Value for Pfizer- Eranz, Torrent- Epez, and Others......158
Ophthalmology Therapeutics......159
Table 152: Market Shares of Leading Ophthalmology Therapeutic Providers by Value Sales Worldwide (2014) - Percentage Breakdown for F. Hoffmann-La Roche AG, Merck Ltd., Novartis AG, Pfizer, Inc., and Others......159
Orphan Disease Therapeutics......160
Table 153: Market Shares of Leading Orphan Disease Therapeutic Providers by Value Sales Worldwide (2014) - Percentage Breakdown for Pfizer, Inc., Sanofi S.A., and Others......160
Women's Health Therapeutics......161
Table 154: Market Shares of Leading Women's Health Therapeutic Providers by Value Sales Worldwide (2014) - Percentage Breakdown for Johnson & Johnson, Merck Ltd., Novo Nordisk A/S, Pfizer, Inc., and Others......161
Cardiology Therapeutics......162
Table 155: Market Shares of Leading Cardiology Therapeutic Providers by Value Sales Worldwide (2014) - Percentage Breakdown for AbbVie, AstraZeneca Plc, Bristol-Myers Squibb Company, Eli Lilly and Company, F. Hoffmann-La Roche AG, Forest Laboratories, Inc., GlaxoSmithKline Plc, Johnson & Johnson, Merck Ltd., Novartis AG, Pfizer, Inc., Sanofi S.A., and Others......162
Table 156: Market Shares of Leading Acipimox Manufacturing Companies in China (2015) - Percentage Share Breakdown by Value for Dalian Pfizer, Lunan Pharmaceutical Group Corporation and Sichuan Kezhida Pharmaceutical Co., Ltd.......163
Table 157: Market Shares of Leading Atorvastatin Manufacturers in China (2015) - Percentage Share Breakdown by Value for Beijing Garlin Pharmaceutical Co., Ltd., Dalian Pfizer Ltd. and Others......164
Table 158: Market Shares of Leading Cardio-Cerebral Vascular (CCV) Drugs Manufacturers in China (2015) - Percentage Share Breakdown by Value for Sihuan Pharmaceutical Holdings Group Ltd., Sanofi S.A., Qilu pharmaceutical Co., Ltd. and Others......165
Diabetes/Metabolic Therapeutics......166
Table 159: Market Shares of Leading Diabetes Drugs Manufacturers by Value Sales Worldwide (2014) - Percentage Breakdown for AstraZeneca Plc, Bristol-Myers Squibb Company, Eli Lilly and Company, GlaxoSmithKline Plc, Johnson & Johnson, Merck Ltd., Novartis AG, Novo Nordisk A/S, Pfizer, Inc., Sanofi S.A., and Others......166
Analgesics Products......167
Table 160: Market Shares of Leading Analgesics Manufacturers by Value Sales Worldwide (2014) - Percentage Breakdown for Johnson & Johnson, Pfizer, Inc., Reckitt Benckiser Plc, and Others......167
Analgesic (Internal Tablet)......168
Table 161: Market Shares of Leading Analgesic (Internal Tablet) Manufacturers by Value Sales at Drug Stores, Food Stores, Mass Merchandisers (including Wal-Mart) in the US (2015) - Percentage Breakdown for Bayer Consumer Health Division, McNeil Consumer Products, Pfizer, Inc., Private Label, and Others......168
Biologic Drugs......169
Table 162: Market Shares of Leading Biologic Drug Manufacturers Worldwide (2015) - Percentage Breakdown by Value for AbbVie Inc., Amgen, Inc. and Pfizer, Inc., Johnson & Johnson, Roche Holding AG and Others......169
Female Hormone Drugs......170
Table 163: Market Shares of Leading Female Hormone Drugs Manufacturers Worldwide (2015) - Percentage Share Breakdown by Value for Naturalendo, Novo Nordisk, Pfizer, Inc., Warner Chilcott and Others......170
Generic Anti-Acne Drugs......171
Table 164: Market Shares of Leading Generic Anti-Acne Drug Manufacturers Worldwide (2015) - Percentage Share Breakdown by Value for Mylan, Perrigo Company, Pfizer, Inc., Sandoz and Others......171
Generic Injectable Drugs......172
Table 165: Market Shares of Leading Generic Injectable Drug Manufacturers Worldwide (2015) - Percentage Breakdown by Volume for Baxter International, Inc., Fresenius SE & Co. KGaA, Hikma Pharmaceuticals Plc, Hospira, Inc., Novartis AG, Pfizer, Inc., Sagent Pharmaceuticals, Inc., Sanofi S.A., and Other......172
Pharmaceutical Drugs......173
Table 166: Market Shares of Leading Pharmaceutical Drugs Manufacturers in the US (2015) - Percentage Breakdown by Value for Amgen, Eli Lilly and Co., Johnson and Johnson Co, Merck & Co., Inc., Pfizer, Inc., and Others......173
Prescription Drugs......174
Table 167: Market Shares of Leading Prescription Drug Companies in the US (2014) - Percentage Breakdown by Value for Amgen, AstraZeneca Plc, Eli Lilly and Company, Genentech, Inc., GlaxoSmithKline plc, Johnson & Johnson, Ltd., Novartis International AG, Pfizer, Inc., Sanofi S.A., Teva Pharmaceutical Industries, Ltd., and Others......174
Table 168: Market Shares of Leading Prescription Drug Companies Spending through Media Ads in the US (2014) - Percentage Breakdown by Value for Amgen, AstraZeneca Plc, Eli Lilly and Company, Genentech, Inc., GlaxoSmithKline plc, Johnson & Johnson, Ltd., Novartis International AG, Pfizer, Inc., Sanofi S.A., and Others......175
Antihypertensive Drugs......176
Table 169: Market Shares of Leading Antihypertensive Drugs Manufacturers Worldwide (2015) - Percentage Share Breakdown by Value for AstraZeneca, Bayer AG, Novartis International AG, Pfizer, Inc., Sanofi-Aventis and Others......176
Baby Food......177
Table 170: Market Shares of Leading Baby Food Manufacturers in Latin America in 2014: Percentage Shares in Sales Value held by Mead Johnson & Company, Nestle SA, and Pfizer, Inc.......177
Table 171: Market Shares of Leading Baby Food Manufacturers in Saudi Arabia in 2014: Percentage Shares in Sales Value held by Abbott Nutrition, Groupe Danone, HiPP UK Ltd., Nestle SA, and Pfizer, Inc.......178
Pediatrics Formula......179
Table 172: Market Shares of Leading Pediatrics Formula Product Manufacturers Worldwide (2015) - Percentage Breakdown by Value for Abbott Laboratories, Danone S.A, Hangzhou Beingmate Group Co., Ltd., Mead Johnson Nutrition Company, Nestle S.A., Pfizer, Inc., and Others......179
Pharmaceuticals......180
Table 173: Market Shares of Leading Pharmaceutical Manufacturers by Value Sales in the US (2014) - Percentage Breakdown for Abbott Laboratories, Amgen Corporation, AstraZeneca Plc, Eli Lilly and Company, F. Hoffmann-La Roche AG, GlaxoSmithKline Plc, Johnson & Johnson, Merck & Co., Inc., Novartis International AG, Pfizer, Inc., Sanofi S.A., Teva Pharmaceutical Industries Ltd., and Others......180
Table 174: Market Shares of Leading Pharmaceutical Companies in Australia (2015) - Percentage Share Breakdown by Value for AstraZeneca, Pfizer, Inc. and Others......181
Table 175: Market Shares of Leading Private Pharmaceutical Companies in South Africa (2015) - Percentage Breakdown by Value for Adcock Ingram, Aspen Pharmacare Holdings Ltd., Cipla Ltd., Merck & Co., Inc., Novartis AG, Sanofi S.A., and Others......182
Generics Pharmaceuticals......183
Table 176: Market Shares of Leading Generics Pharmaceutical Companies in Brazil (2014) - Percentage Breakdown by Value for Achelois Pharmaceuticals, Inc., Ems Sigma Pharma Group, Eurofarma Laboratórios, Hypermarcas S.A., Pfizer, Inc., Sanofi - Medley Indústria Farmacêutica Ltda and Others......183
Table 177: Market Shares of Leading Branded Generic Pharmaceutical Companies in Brazil (2014) - Percentage Breakdown by Value for Cimed Indústria Farmacêutica Ltda, Ems Sigma Pharma Group, Hypermarcas S.A., Pfizer, Inc., Takeda Pharmaceutical Company Limited, União Química Farmacêutica Nacional S.A and Others......184
Prescription Pharmaceuticals......185
Table 178: Market Shares of Leading Prescription Pharmaceutical Companies in the US (2014) - Percentage Market Share Breakdown by Volume Sales for Actavis Plc, Amneal, Inc., Endo Pharma, Inc., Lupin Pharmaceuticals, Inc., Mylan Labs,Inc., Novartis International AG, Pfizer, Inc., Teva Pharmaceutical Industries Ltd., and Others......185
RX Pharmaceuticals......186
Table 179: Market Shares of Leading RX Pharmaceutical Companies in Brazil (2014) - Percentage Breakdown by Value for Achelois Pharmaceuticals, Inc., Eurofarma Laboratórios, Hypermarcas S.A.,Pfizer, Inc., Roche AG, Sanofi - Medley Indústria Farmacêutica Ltda and Others......186
Central Nervous System (CNS) Medicine......187
Table 180: Market Shares of Leading Central Nervous System Medicine Manufacturers by Value Sales Worldwide (2014) - Percentage Breakdown for AstraZeneca Plc (AZN), Bristol-Myers Squibb Company (BMY), Eli Lilly And Co (LLY), GlaxoSmithKline Plc (GSK), Johnson & Johnson, Merck & Co., Inc. (MRK), Novartis AG (NVS), Pfizer, Inc. (PFE), Shire Plc (SHPGY), and Others......187
Epilepsy Medicine......188
Table 181: Market Shares of Leading Epilepsy Medicine Manufacturers by Value Sales Worldwide (2014) - Percentage Breakdown for GlaxoSmithKline Plc, Johnson & Johnson, Novartis AG, Pfizer, Inc., Sanofi S.A., and Others......188
Cough, Cold Allergy Medicine......189
Table 182: Market Shares of Leading Cough, Cold Allergy Medicine Manufacturers Worldwide (2014) - Percentage Breakdown by Value Sales for Johnson & Johnson, Pfizer, Inc., Procter & Gamble Co., Reckitt Benckiser Plc, and Others......189
Clinical Nutritional Products......190
Table 183: Market Shares of Leading Clinical Nutritional Products Manufacturers Worldwide (2015) - Percentage Breakdown by Value for Abbott Nutriton, Inc., Dannon Group, Mead Johnson Nutrition Company, Nestlé S.A., Pfizer, Inc., and Others......190
Consumer Health Products......191
Table 184: Market Shares of Leading Consumer Health Product Manufacturers in US (2015) - Percentage Breakdown by Value for Bayer AG, Johnson & Johnson Inc, Living Essentials, Merck & Co., Inc., NBTY, Inc., Novartis AG, Pfizer Inc, Procter & Gamble Co., Private-Label and Others......191
Table 185: Market Shares of Leading Consumer Health Product Producers by Value Sales in the US (2014) - Percentage Breakdown for Bayer AG, General Nutrition Centres, Inc., Glanbia Plc, GlaxoSmithKline Plc, Herbalife Ltd., Johnson & Johnson, Inc., Living Essentials, LLC, Merck & Co, Inc., NBTY, Inc., Novartis AG, Otsuka Holdings Co., Ltd., Pfizer, Inc., Prestige Brands Holdings, Inc., Procter & Gamble Co., Reckitt Benckiser Plc, Sanofi SA, Private Label, and Others......192
Table 186: Market Shares of Leading Consumer Health Product Producers by Value Sales in the US OTC Market (2014) - Percentage Breakdown for Bayer AG, GlaxoSmithKline Plc., Johnson & Johnson Inc., Merck & Co Inc., Novartis AG, Pfizer Inc., Prestige Brands Holdings Inc., Procter & Gamble Co., Reckitt Benckiser Plc., Sanofi S.A., Private Label and Others......193
Dermatological Products......194
Table 187: Market Shares of Leading Dermatological Product Manufacturers by Value Sales Worldwide (2014) - Percentage Breakdown for Johnson & Johnson, Pfizer, Inc., Reckitt Benckiser Plc, and Others......194
Herbal Products......195
Table 188: Market Shares of Leading Herbal Products Producers by Value Sales in the US (2014) - Percentage Breakdown for General Nutrition Centres, Inc., GlaxoSmithKline Plc, Herbalife Ltd., Johnson & Johnson, Inc., NBTY, Inc., Novartis AG, Pfizer, Inc., Prestige Brands Holdings, Inc., Procter & Gamble Co., Sanofi SA, Private Label and Others......195
Adult Mouth Product......196
Table 189: Market Shares of Leading Adult Mouth Product Manufacturers by Value Sales Worldwide (2014) - Percentage Share Breakdown for Johnson & Johnson, Reckitt Benckiser Plc, Pfizer, Inc., PL, and Others......196
Paediatric Health Products......197
Table 190: Market Shares of Leading Paediatric Health Product Companies by Value Sales in the US (2014) - Percentage Breakdown for Bayer AG, Herbalife Ltd., Johnson & Johnson Inc., Merck & Co Inc., NBTY Inc., Novartis AG, Pfizer Inc., Prestige Brands Holdings Inc., Procter & Gamble Co., Reckitt Benckiser Plc., Sanofi S A, Private Label and Others......197
Table 191: Market Shares of Leading Pediatric Health Product Manufacturers in the US (2015) - Percentage Breakdown by Value for Bayer AG, Johnson & Johnson Inc, Merck & Co., Inc., Novartis AG, Pfizer Inc, Prestige Brands Holdings Inc, Reckitt Benckiser Plc, Private-Label and Others......198
Allergy Care Products......199
Table 192: Market Shares of Leading Allergy Care Product Companies by Value Sales in the US (2014) - Percentage Breakdown for Johnson & Johnson Inc., Merck & Co Inc., Novartis AG, Pfizer Inc., Prestige Brands Holdings Inc., Sanofi S A, Private Label and Others......199
Calming and Sleeping Products......200
Table 193: Market Shares of Leading Calming and Sleeping Product Manufacturers by Value Sales Worldwide (2014) - Percentage Breakdown for Johnson & Johnson, Pfizer, Inc., Procter & Gamble Co., and Others......200
Amlodipine Besylate Tablets......201
Table 194: Market Shares of Leading Amlodipine Besylate Tablet Manufacturers for Antihypertensive Therapy Worldwide (2015) - Percentage Share Breakdown by Hospital Sales for Pfizer, Inc., Saike Pharmaceutical Co., Ltd., Yangtze River Pharmaceutical Group, and Others......201
Atorvastatin Calcium Tablets (A LE)......202
Table 195: Market Shares of Leading Atorvastatin Calcium Tablets (A LE) Manufacturers Worldwide (2015) - Percentage Breakdown by Value for Beijing Jialin Pharmaceutical Co, Ltd., Pfizer, Inc. and Others......202
Generic Anti-acne......203
Table 196: Market Shares of Leading Generic Anti-acne Manufacturers Worldwide (2015) - Percentage Share Breakdown by Value for Mylan N.V., Perrigo Company plc, Pfizer, Inc., Prasco Laboratories, Rouses Point Pharmaceuticals LLC, Sandoz Inc., Taro Pharmaceutical Industries Ltd., and Private Label......203
Multivitamins......204
Table 197: Market Shares of Leading Multivitamin Manufacturers by Value Sales through Drug Stores, Food Stores, Mass Merchandisers (including Wal-Mart) in the US (2015) - Percentage Share Breakdown for Bausch & Lomb, Inc., Bayer AG, Church & Dwight Co., Inc., Pfizer, Inc., Pharmative, LLC, Reckitt Benckiser Group plc, Private Label, and Others......204
Table 198: Market Shares of Leading Multivitamin Manufacturers through Supermarkets, Drug Stores, and Mass Merchandisers in the US (2015) - Percentage Breakdown by Value for Airborne (Reckitt Benckiser Group plc), Bausch & Lomb Inc., Bayer AG, Church & Dwight Co., Inc., Nature's Way Products, LLC, Pfizer, Inc., Private Label, and Others......205
Paediatric Nutritional......206
Table 199: Market Shares of Leading Paediatric Nutritional Companies by Value Sales Worldwide (2014) - Percentage Breakdown for Abbott Laboratories, Groupe Danone, Mead Johnson & Co., Nestlé S.A, Pfizer Inc. and Others......206
Over-The-Counter (OTC)......207
Table 200: Market Shares of Leading Over-the-Counter (OTC) Product Manufacturers in US (2015) - Percentage Breakdown by Value for Bayer AG, GlaxoSmithKline Plc, Johnson & Johnson Inc, Merck & Co., Inc., Novartis AG, Pfizer Inc, Prestige Brands Holdings Inc, Procter & Gamble Co., Reckitt Benckiser Plc, Sanofi S.A., Private-Label and Others......207
Table 201: Market Shares of Leading Over the Counter Drugs Manufacturers Worldwide (2015) - Percentage Share Breakdown by Value for GlaxoSmithKline-Novartis International AG, Johnson & Johnson and Others......208
Cough Syrup......209
Table 202: Market Shares of Leading Cough Syrup Manufacturers through Drug Store in the US (2015) - Percentage Breakdown by Value for Novartis AG, Pfizer, Inc., Procter & Gamble Co., ReckittBenckiser, Inc., and Others......209
Table 203: Market Shares of Leading Cough Syrup Manufacturers through Food Stores in the US (2015) - Percentage Breakdown by Value for Honey Naturals LLC, Pfizer, Inc., Prestige Brands Holdings, Inc., Procter and Gamble Co., Reckitt Benckiser, Inc., Private Label, and Others......210
Irinotecan......211
Table 204: Market Shares of Leading Irinotecan Manufacturers in the US (2015) - Percentage Breakdown by Value for APP Pharmaceuticals, Inc., Hospira, Inc., Novartis International AG, Pfizer, Inc. and Teva Pharmaceutical Industries Ltd.......211
Cough and Cold Remedies......212
Table 205: Market Shares of Leading Manufacturers for Cough and Cold Remedies Worldwide (2015) - Percentage Breakdown by Value for Bayer AG, Johnson & Johnson, Pfizer, Inc., Procter & Gamble Co., Reckitt Benckiser Group Plc, Sanofi S.A., Private Label and Others......212
Prefilled Syringes......213
Table 206: Market Shares of Leading Prefilled Syringes Buyers by Value Sales Worldwide (2014) - Percentage Breakdown for GlaxoSmithKline Plc (GSK), Novo Nordisk A/S (NVO), Pfizer, Inc. (PFE), Sanofi S.A., and Others......213
Therapeutic Dermatology (excluding Aesthetics) Medicines......214
Table 207: Market Shares of Leading Therapeutic Dermatology (excluding Aesthetics) Medicine Manufacturers by Value Sales Worldwide (2014) - Percentage Breakdown for AbbVie, Inc. (ABBV), Galderma S.A., GlaxoSmithKline Plc (GSK), Johnson & Johnson, Merck & Co., Inc. (MRK), Pfizer, Inc. (PFE), Amgen, Inc. (AMGN), Valeant Pharmaceuticals Intl, Inc., Dermik Laboratories, and Others......214
Table 208: Market Shares of Leading Derma Generics Manufacturers in the US (2015) - Percentage Share Breakdown by Value for Actavis plc, Perrigo Company plc, Sandoz, Taro Pharmaceutical Industries Ltd. and Others......215
Infectious Disease Drugs......216
Table 209: Market Shares of Leading Infectious Disease Drugs Manufacturers by Value Sales Worldwide (2014) - Percentage Breakdown for AbbVie, AstraZeneca Plc, Bristol- Myers Squibb Company, Eli Lilly and Company, F. Hoffmann-La Roche AG, Forest Laboratories, Inc., GlaxoSmithKline Plc, Johnson & Johnson, Merck Ltd., Novartis AG, Pfizer, Inc., Sanofi S.A., and Others......216
Vitamins......217
Table 210: Market Shares of Leading Vitamin Manufacturers through Supermarkets, Drug Stores and Mass Merchandisers (excluding Wal-Mart) in the US (2015) - Percentage Breakdown by Value for Bausch & Lomb, Inc., Bayer AG, Church & Dwight Co., Inc., Pfizer, Inc., Reckitt Benckiser Group plc, and Others......217
Table 211: Market Shares of Leading Vitamins & Dietary Supplement Product Producers by Value Sales in the US (2014) - Percentage Breakdown for Bayer AG, General Nutrition Centres, Inc., GlaxoSmithKline Plc, Herbalife Ltd., Johnson & Johnson, Inc., Living Essentials, LLC, NBTY, Inc., Novartis AG, Otsuka Holdings Co., Ltd., Pfizer, Inc., Procter & Gamble Co., Private Label and Others......218
Insulin......219
Table 212: Market Shares of Leading Insulin Drug Manufacturers in India (2014) - Percentage Breakdown by Value for Biocon Ltd., Cadila Pharmaceuticals Ltd., Eli Lilly and Company India Pvt. Ltd., Lupin Pharmaceuticals, Inc., Novo Nordisk India Ltd., Pfizer India Ltd., Ranbaxy Laboratories Ltd., Sanofi India Ltd., Shreya Life Sciences Pvt. Ltd., USV Ltd., and Wockhardt Ltd.......219
Glargine......220
Table 213: Market Shares of Leading Glargine Drug Manufacturers in India (2014) - Percentage Breakdown by Value for Biocon Limited, Pfizer India Limited, Sanofi India Limited and Wockhardt Ltd.......220
Pet Health Products......221
Table 214: Market Shares of Leading Pet Health Product Manufacturers in the US (2015) - Percentage Breakdown by Value for Bayer AG, Merial Ltd., Pfizer Ltd., and Others......221
Domestic Pharmacies......222
Table 215: Market Shares of Leading Pharmaceutical Companies in India (2014) - Percentage Breakdown by Value for Abbott India Limited, Alembic Pharmaceuticals Limited, Alkem Laboratories, Aristo Pharmaceuticals Pvt Ltd., Cadila Pharmaceuticals Limited., Cipla Global Limited, Dr. Reddy's Laboratories., Emcure Pharmaceuticals Ltd., FDC Limited., GlaxoSmithKline Pharmaceuticals Ltd., Glenmark Pharmaceuticals, Intas Pharmaceuticals limited, Lupin Limited, Macleods Pharmaceuticals Ltd., Mankind Pharma, Micro Labs Ltd., Novartis AG, Pfizer Limited, India., Ranbaxy Laboratories Limited, Sanofi India Limited, Sun India Pharmacy (P) Ltd., Torrent Pharmaceuticals Limited., Unichem Laboratories, USV Limited., Wockhardt Ltd., and Others......222
Table 216: Pfizer, Inc.’s Sales by Product Segment Worldwide (2011-2013) in US$ Million for Biopharmaceutical Products and Consumer Healthcare......223